In vitro effect of gonadotropin-releasing hormone agonist on natural killer cell cytolysis in women with and without endometriosis

American Journal of Obstetrics and Gynecology

Volumn 190, Issue 1, 2004, Pages 44-49

  Wong, Kenneth H H ^a   Simon, James A ^b,c  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b Women's Health Research Center   (United States)

^c NONE   (United States)

Author keywords

Endometriosis; Gonadotropin releasing hormone agonist; Natural killer cell

Indexed keywords

CHROMIUM 51; GONADORELIN AGONIST; LEUPRORELIN;

ADULT; ARTICLE; CELL ACTIVITY; CELL ASSAY; CELL STRAIN K 562; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLYSIS; DRUG EFFECT; DRUG TARGETING; ENDOMETRIOSIS; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROCYTOSIS; NATURAL KILLER CELL; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 0742269646     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2003.08.032     Document Type: Article

References (31)

1. Gazvani R, Templeton A. Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction 2002;123:217-26.
2. Witz CA. Pathogenesis of endometriosis. Gynecol Obstet Invest 2002;53(Suppl):52-62.
3. Dmowski WP, Gebel HM, Braun DP. The role of cell-mediated immunity in pathogenesis of endometriosis. Acta Obstet Gynecol Scand Suppl 1994;159:7-14.
4. Oosterlynck DJ, Cornillie FJ, Waer M, Vandeputte M, Koninckx PR. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril 1991;56:45-51.
5. Vigano P, Vercellini P, Di Blasio AM, Colombo A, Candiani GB, Vignali M. Deficient antiendometrium lymphocyte-mediated cytotoxicity in patients with endometriosis. Fertil Steril 1991;56: 894-9.
6. Oosterlynck DJ, Meuleman C, Waer M, Vandeputte M, Koninckx PR. The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis. Fertil Steril 1992;58: 290-5.
7. Garzetti GG, Ciavattini A, Provinciali M, Fabris N, Cignitti M, Romanini C. Natural killer cell activity in endometriosis: correlation between serum estradiol levels and cytotoxicity. Obstet Gynecol 1993;81:665-8.
8. Wilson TJ, Hertzog PJ, Angus D, Munnery L, Wood EC, Kola I. Decreased natural killer cell activity in endometriosis patients: relationship to disease pathogenesis. Fertil Steril 1994;62:1086-8.
9. Garzetti GG, Ciavattini A, Provinciali M, Muzzioli M, Di Stefano G, Fabris N. Natural killer activity in stage III and IV endometriosis: impaired cytotoxicity and retained lymphokine responsiveness of natural killer cells. Gynecol Endocrinol 1995;9: 125-30.
10. + lymphocyte subpopulation are decreased in women with stage III-IV endometriosis. Hum Reprod 1995;10:2671-5.
11. Lessey BA, Metzger DA, Haney AF, McCarty KS Jr. Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: comparison with normal endometrium during the menstrual cycle and the effect of medical therapy. Fertil Steril 1989;51:409-15.
12. Sekiya S, Kamiyama M, Takamizawa H. In vivo and in vitro tests of inhibitory effect of progesterone on cell-mediated immunity in rats bearing a syngeneic uterine adenocarcinoma. J Natl Cancer Inst 1975;54:769-71.
13. Mori T, Kobayashi H, Nishimura T, Mori TS, Fujii G, Inou T. Inhibitory effect of progesterone on the phytohaemagglutinin-induced transformation of human peripheral lymphocytes. Immunol Commun 1975;4:519-27.
14. McMurray RW, Suwannaroj S, Ndebele K, Jenkins JK. Differential effects of sex steroids on T and B cells: modulation of cell cycle phase distribution, apoptosis and bcl-2 protein levels. Pathobiology 2001;69:44-58.
15. Laskarin G, Tokmadzic VS, Strbo N, et al. Progesterone induced blocking factor (PIBF) mediates progesterone induced suppression of decidual lymphocyte cytotoxicity. Am J Reprod Immunol 2002; 48:201-9.
16. Hill JA, Barbieri RL, Anderson DJ. Immunosuppressive effects of danazol in vitro. Fertil Steril 1987;48:414-8.
17. Vigano P, Di Blasio AM, Busacca M, Sabbadini MG, Vignali M. Danazol suppresses both spontaneous and activated human lymphocyte-mediated cytotoxicity. Am J Reprod Immunol 1992; 28:38-42.
18. Vigano P, Di Blasio AM, Busacca M, Vignali M. Immunosuppressive effect of danazol on lymphocyte-mediated cytotoxicity toward human endometrial stromal cells. Gynecol Endocrinol 1994;8:13-9.
19. Mori H, Nakagawa M, Itoh N, Wada K, Tamaya T. Danazol suppresses the production of interleukin-1 beta and tumor necrosis factor by human monocytes. Am J Reprod Immunol 1990;24: 45-50.
20. Garzetti GG, Ciavattini A, Provinciali M, Muzzioli M, Di Stefano G, Fabris N. Natural cytotoxicity and GnRH agonist administration in advanced endometriosis: positive modulation on natural killer activity. Obstet Gynecol 1996;88:234-40.
21. Hsu CC, Lin YS, Wang ST, Huang KE. Immunomodulation in women with endometriosis receiving GnRH agonist. Obstet Gynecol 1997;89:993-8.
22. Seaman WE, Gindhart TD. Effect of estrogen on natural killer cells. Arthritis Rheum 1979;22:1234-40.
23. Ferguson MM, McDonald FG. Oestrogen as an inhibitor of human NK cell cytolysis. FEBS Lett 1985;191:145-8.
24. Gabrilovac J, Zadjelovic J, Osmak M, Suchanek E, Zupanovic Z, Boranic M. NK cell activity and estrogen hormone levels during normal human pregnancy. Gynecol Obstet Invest 1988;25: 165-72.
25. Ablin RJ, Bartkus JM, Gonder MJ. In vitro effects of diethyl- stilboestrol and the LHRH analogue leuprolide on natural killer cell activity. Immunopharmacology 1988;15:95-101.
26. Katz P, Simone CB, Henkart PA, Fauci AS. Mechanisms of antibody-dependent cellular cytotoxicity: the use of effector cells from chronic granulomatous disease patients as investigative probes. J Clin Invest 1980;65:55-63.
27. Bryant J, Day R, Whiteside TL, Herberman RB. Calculation of lytic units for the expression of cell-mediated cytotoxicity. J Immunol Methods 1992;146:91-103.
28. Herberman RB, Djeu J, Kay HD, et al. Natural killer cells: characteristics and regulation of activity. Immunol Rev 1979;44: 43-70.
29. Costa O, Mulchahey JJ, Blalock JE. Structure and function of luteinizing hormone - releasing hormone (LHRH) receptors on lymphocytes. Prog Neurol Endocrinol Immunol 1990;3:55-60.
30. Standaert FE, Chew BP, De Avila D, Reeves JJ. Presence of luteinizing hormone-releasing hormone binding sites in cultured porcine lymphocytes. Biol Reprod 1992;46:997-1000.
31. Seaman WE, Blackman MA, Gindhart TD, Roubinian JR, Loeb JM, Talal N. beta-Estradiol reduces natural killer cells in mice. J Immunol 1978;121:2193-8.